1 Min Read
Jan 30 (Reuters) - Madrigal Pharmaceuticals Inc:
* MADRIGAL ANNOUNCES ACCEPTANCE OF MGL-3196 ABSTRACT FOR A MAIN PLENARY PRESENTATION AT THE INTERNATIONAL LIVER CONGRESS™ 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.